Evaluating the link between heart failure and cognitive impairment using Doppler imaging
Official title: TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Patients With Heart Failure and Presence/Absence of Atherosclerotic Carotid Artery Stenosis
Run by John Paul II Hospital, Krakow · NCT05250349 · Data updated 2026-11-12
This study is trying to see if heart failure affects thinking and memory in younger patients by looking at blood flow in the brain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | John Paul II Hospital, Krakow Academic / other |
| Locations | 1 site (Krakow, MP) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | September 1, 2022 |
| Study ends | September 1, 2027 |
| Registry record updated | February 22, 2022 |
| Trial ID | NCT05250349 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are clinically stable heart failure patients with mildly reduced or reduced ejection fraction.
✕Probably not a fit
Patients with severe irreversible diseases, previously diagnosed dementia, or acute decompensated heart failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
TRACE-IMPAIR is a prospective observational study that investigates the relationship between heart failure (HF) and cognitive impairment by assessing carotid and cerebral blood flow using Doppler ultrasonography. The study includes clinically stable patients with HF and employs neuropsychological tests to evaluate cognitive function. By focusing on both mildly reduced and reduced ejection fraction patients, the study aims to clarify the role of cerebral flow impairment in cognitive dysfunction, particularly in younger patients under 60 years old. This single-center study is conducted at the John Paul II Hospital in Krakow.
Why it matters
Potential benefit: If successful, this study could enhance understanding of cognitive dysfunction in heart failure patients, potentially leading to improved management strategies.
How similar studies have gone: While previous studies have explored similar themes, they often involved small patient groups and varied methodologies, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically stable patients (NYHA I-III symptoms) with HF (for at least 6 months) either of ischemic or inflammatory etiology as well as genetic cardiomyopathies * Signed informed consent form * Consent to imaging studies: echocardiography, carotid and transcranial Doppler sonography and neuropsychological tests (MMSE and MoCA). Exclusion Criteria: * Co-existing, severe, irreversible disease (e.g. advanced cancer) * Previously diagnosed dementia (including severe dementia - MMSE and MoCA score \<10) * Psychiatric condition which may influence cognitive function * Acute, decompensated HF * Reversible cause of HF - tachyarrhytmic, peripartum or toxic cardiomyopathy, acute myocarditis, acute myocardial infarction * Aortic stenosis * Cerebral stroke in the preceding 3 months * Lack of transcranial Doppler acoustic window * Echocardiographic projections precluding adequate measurements * Anemia with Hemoglobin \< 8 g/dl * Alcohol or psychoactive agents abuse
Where it's running
-
Department of Cardiac and Vascular Diseases, The John Paul II Hospital
Krakow, Mp, Poland Recruiting
Study contacts
- Principal investigator: Piotr Musialek, MD, DPhil — John Paul II Hospital
- Study coordinator: Piotr Musialek, MD, DPhil
- Email: pmusialek@szpitaljp2.krakow.pl
- Phone: +48126142287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ViCCY: a caregiver self-care program for HF patients with cognitive impairment
This study tests a 6-month, 10-session virtual coaching program for informal caregivers of adults with heart failure and cognitive impairment to see if it improves caregiver mental health and patient outcomes.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Vericiguat for people with heart failure and thinking problems.
This trial will test whether adding vericiguat to usual care helps brain blood-vessel health and improves thinking and function in adults with chronic heart failure and mild-to-moderate cognitive impairment.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.